Brief: Shanghai Haohai Biological Technology says trading in H shares of co has been halted
15/11/2016 05:30
Nov 15 (Reuters) - Shanghai Haohai Biological Technology Co
Ltd 6826.HK
* Seeks trading halt pending announcement in relation to
transaction of co involving acquisition of ophthalmology
products trading company
* Trading in H shares of co has been halted with effect from
1:00 p.m. On 15 nov
Source text for Eikon: urn:newsml:reuters.com:*:nHKS1Vwpgc
Further company coverage: 6826.HK
((bangalore.newsroom@thomsonreuters.com ;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.